Skip to content

APEMESH II - Perineal Reconstruction

Apemesh II - Perineal Reconstruction With Mesh Enhanced Gluteus Plasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04779125
Enrollment
30
Registered
2021-03-03
Start date
2021-03-19
Completion date
2022-03-01
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

abdominoperineal resection, perineal reconstruction

Brief summary

The objective of this pilot study is to assess the safety, functional outcome, feasibility and the potential benefits of synthetic mesh strip and gluteus flap reconstruction in perineum in case-control setting.

Detailed description

Several studies have reported over 30% morbidity with perineal wound healing after abdominoperineal resection. Preoperative radiotherapy seems to be a strong predictor for perineal complications. Musculocutaneus flaps and use of biological mesh seem to minimize perineal morbidity.

Interventions

PROCEDUREGluteus plasty enhanced with Progrip self gripping mesh

Intervention group will be compared to historical patients in a case-control setting. Intervention group will have a mesh enhanced gluteus plasty made to reconstruct perineum after abdominoperineal resection.

Sponsors

University of Oulu
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All patients, who have an abdominoperineal reconstruction for rectal cancer, will have a mesh enhanced gluteus plasty. The patients will be compared to historical cohort.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Curative intent abdominoperineal resection and permanent colostomy

Exclusion criteria

* Patient with a comorbid illness or condition that would preclude the use of surgery (ASA 4- 5) * Immunosupression (cortisone \>10mg/day) or severe malnutrition (BMI \<20) * Diabetes with 1 or more organ damage * Dialysis treatment * Hepatic cirrhosis Child-Bugh B-C * Potentially curable resection not possible * Patient undergoing emergency procedures * Metastatic disease * Vaginal resection, pelvic exenteration and sacrum resection * Vaginal perforation * Pelvic abscess or perforated tumor * Pregnant or suspected pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Complications30 daysComprehensive complication index

Secondary

MeasureTime frameDescription
Reoperation rate30 daysReoperation rate
Operative time30 daysOperative time to reconstruct perineum
Length of hospital stay30 daysPrimary length of stay at the hospital
Costs of treatment materials30 daysCosts of treatment materials
Surgical site infections30 daysSurgical site infections
Perineal fistula30 daysPerineal sinus or fistula
Perineal hernia12 monthsPerineal hernia incidence
Gluteus muscle function measured by time stands test12 monthsGluteus muscle function measured by time stands test
Total perineal healing time1 yearTime from operation to complete perineal healing

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026